US FDA, Sponsors Eye Best Practices For Virtual AdComms
Executive Summary
Agency has created a centralized team to help review divisions with virtual advisory committee preparations and is trying to notify sponsors earlier in the review process about the need for a panel; sponsors cite importance of having a back channel of communications so team members can communicate with each other while an AdComm is underway.
You may also be interested in...
Some US FDA Advisory Committee Meetings Likely To Remain Virtual Post-Pandemic
Peter Stein says FDA will set criteria for holding a virtual meeting and will be seeking stakeholder feedback.
Pondering The Future Of In-Person Meetings At The US FDA
Stakeholders believe virtual meetings should remain an option going forward, but that in-person sessions should still be convened in many cases.
US FDA’s Cavazzoni Says Retaining Virtual Meetings Could Improve Communications Going Forward
One of the lessons learned from the pandemic may be that virtual meetings can be used in place of an in-person session more often.